Neurofibromatosis Type 1 Cutaneous Neurofibroma Longitudinal Natural History Study and Selumetinib Clinical Trial

syn8012530

Created By Xindi Guo xindi.guo

dataType: Volume
grantDOI: https://doi.org/10.54464/pc.gr.147655
studyName: Neurofibromatosis Type 1 Cutaneous Neurofibroma Longitudinal Natural History Study and Selumetinib Clinical Trial
dataStatus: Under Embargo
initiative: Francis S. Collins Scholars Program
studyLeads: Ashley Cannon
studyStatus: Completed
diseaseFocus: Neurofibromatosis type 1
grantEndDate: 1561852800000
institutions: University of Alabama Medical Center
fundingAgency: NTAP
manifestation: Cutaneous Neurofibroma
embargoEndDate: 1593475200000
grantStartDate: 1467331200000
relatedStudies: syn51356860 syn29866703 syn22266606 syn51298831
studyFileviewId: syn11678417
Welcome to the NTAP NF1 Dermal Neurofibroma Longitudinal Natural History Study and Selumetinib Clinical Trial Forum
syn11678417
syn26956660

Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this AJAX application crawl link

Neurofibromatosis Type 1 Cutaneous Neurofibroma Longitudinal Natural History Study and Selumetinib Clinical Trial

syn8012530

Drop files to upload

Neurofibromatosis Type 1 Cutaneous Neurofibroma Longitudinal Natural History Study and Selumetinib Clinical Trial page is loading…